by Ethan Webb | Sep 5, 2026 | Regulation
Stimulants are involved in a rising share of overdose deaths, but stimulant use disorder has no FDA-approved medication, leaving a treatment system built around drugs with none to offer. Key TakeawaysStimulants are now central to the overdose crisis: Methamphetamine...
by Ethan Webb | Jul 22, 2026 | Technology
Contingency management is the evidence-based standard for stimulant use disorder, but reimbursement gaps and anti-kickback law keep the treatment rare in practice. Key Takeaways The evidence is not in question: Decades of trials show contingency management, which...
